What we think

Read our latest insights, ideas, and perspectives. A cross-section of our latest thinking across industries and capabilities can be found here.

Trending Topics

The Growth Blueprint podcast
Automotive Study
The new economics of neobanking
Better Health
Global Pricing Study 2025
Tariffs, pricing, and power
Global Travel Trends 2026
40 years of Better Growth in industrials
Better Growth
SK Insights: CDMO pricing 2025: Better value communication for growth
Oct 17, 2025 | Blog

CDMO pricing 2025: Better value communication for growth

Healthcare & Life Sciences Healthcare B2B Suppliers
Simon-Kucher Insights: From pandemic spike to permanent shift: The rise of at-home diagnostics 
Oct 16, 2025 | Blog

The rise of at-home diagnostics

Healthcare & Life Sciences Diagnostics
launch excellence blog image
Oct 13, 2025 | Blog

Closing the biotech launch gap

Healthcare & Life Sciences Pharma & Biotechnology
Simon-Kucher case study: Global portfolio pricing and launch strategy for innovative oncology sequencing tests
| Case Study

Global portfolio pricing and launch strategy for innovative oncology sequencing portfolio

Healthcare & Life Sciences Diagnostics
Simon-Kucher Blog: Minimal Residual Disease in solid tumors: The next big thing in oncology diagnostics
Sep 15, 2025 | Blog

MRD in solid tumors: The future of oncology diagnostics

Healthcare & Life Sciences Diagnostics
Simon-Kucher insights: How liquid biopsies are driving change in cancer care
Sep 10, 2025 | Blog

Liquid biopsies: Challenges and growth drivers

Healthcare & Life Sciences Diagnostics
Case study banner_Assessing market fit and guiding R&D decisions for a novel diagnostics solution
| Case Study

Assessing market fit and guiding R&D decisions for a novel diagnostics solution

Healthcare & Life Sciences Diagnostics
Global
Simon-Kucher Blog: From chaos to control: How pharma companies can master global price management
Aug 29, 2025 | Blog

How pharma companies move from pricing chaos to control

Healthcare & Life Sciences Pharma & Biotechnology
Middle east & APAC
emerging thumb
Aug 25, 2025 | Perspective | Whitepaper

The new model for equitable access in LMICs

Healthcare & Life Sciences Healthcare Providers
Middle east & APAC
Image header: 2025 NRDL outlook: A fork in the road
Aug 19, 2025 | Blog

NRDL 2025 outlook

Healthcare & Life Sciences Pharma & Biotechnology
Middle east & APAC
Blog_What the latest volume-based procurement changes in China mean for pharma
Jul 23, 2025 | Blog

VoBP shifts in China: What pharma needs to know

Healthcare & Life Sciences Pharma & Biotechnology
Blog_Patient retention in the digital age
Jul 15, 2025 | Blog

Patient retention in the digital age

Healthcare & Life Sciences Healthcare Providers
thumbnail
| Case Study

New regional price strategy drives 20% revenue growth for a women’s health network

Healthcare & Life Sciences Healthcare Providers
Case study:How we identified a pricing opportunity for a novel precision medicine screening tool
| Case Study

How we identified a pricing opportunity for a novel precision medicine screening tool

Healthcare & Life Sciences Diagnostics
Case study: Commercial quick wins reinforce pricing power for top diagnostics provider
| Case Study

Commercial quick wins reinforce pricing power for top diagnostics provider

Healthcare & Life Sciences Healthcare Providers
blog 2
Jul 01, 2025 | Blog

New revenue streams with digital platforms in healthcare

Healthcare & Life Sciences Healthcare Providers
Language
Search